Inotuzumab
Inotuzumab (Humanized Anti-CD22 Recombinant Antibody) is a humanized IgG4 antibody targeting CD22. This naked antibody can be used to synthesize antibody-active molecule conjugators [Inotuzumab ozogamicin] and to study acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
Product Specifications
CAS Number
1660159-36-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
Approximately 146.48 kDa.
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
ADC Antibody
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
E16FMN244.2-025U 25 µg
PE-Cy7 anti-mouse CD244.2 (2B4 B6 AlloAntigen)
Sign In for Pricing
View Details 
K1958104 1.0 µg DNA
RPL29P30 sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details GTR15199162 1 Vial
Lentiviral mouse Ddx56 shRNA (UAS) - Lentiviral mouse Ddx56 shRNA (UAS, GFP) plasmid
Sign In for Pricing
View Details K2751006 1.0 µg DNA
C4orf51 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details